Interactive Brokers Group's Next Earnings Report Tomorrow Could Send the Stock Soaring. Here's Why.
Key PointsThe summer stock market was livelier than many expected it to be.
Aggregator
Interactive Brokers Group's Next Earnings Report Tomorrow Could Send the Stock Soaring. Here's Why.
Key PointsThe summer stock market was livelier than many expected it to be.
News Flash: Trumpflation Is Expected to Ramp Up the Fed's Rate-Hiking Cycle in 2027
Key PointsThe Bureau of Labor Statistics will release the September inflation report today, Oct. 14.
News Flash: Trumpflation Is Expected to Ramp Up the Fed's Rate-Hiking Cycle in 2027
Key PointsThe Bureau of Labor Statistics will release the September inflation report today, Oct. 14.
Grab These 3 High-Yield Bond Funds for Impressive Returns
We share with you three top-ranked high-yield bond mutual funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).
The Stock Market Is Making a Move That Warren Buffett Has Warned About. Here's What History Says Comes Next.
Key PointsBuffett warned 25 years ago about a specific stock market scenario.
The Stock Market Is Making a Move That Warren Buffett Has Warned About. Here's What History Says Comes Next.
Key PointsBuffett warned 25 years ago about a specific stock market scenario.
Zambia, IRH Reaffirm Copper Partnership After Alleged Breaches
Zambia’s state mining firm and Abu Dhabi’s International Resources Holding reaffirmed their commitment to working together, following allegations of funding breaches at their jointly-owned Mopani copper complex.
The Saudi Arabia of Europe? How Türkiye's summer transfer window changed the game
Turkish clubs compete for prestige through the transfer market and this summer took things to yet another level as Mo Salah, Rafael Leão and other big names arrived.
Looking for Upside? These Cryptocurrencies Have the Potential to Double in Value in 2027.
Key PointsA dozen cryptocurrencies have posted returns of 100% or higher during the past three months.
Looking for Upside? These Cryptocurrencies Have the Potential to Double in Value in 2027.
Key PointsA dozen cryptocurrencies have posted returns of 100% or higher during the past three months.
More Adult Kids Are Going ‘No Contact’ With Parents. How Will It Affect Generational Wealth?
A perceived rise in estrangement between adult children and parents could affect the housing market and intergenerational wealth transfer.
'Possessed' Davidson fills Weir gap as Scots set up glamour Sweden tie
Erin Cuthbert praises Lauren Davidson as Scotland overcome Caroline Weir's absence to set up a World Cup play-off tie with Sweden.
Micron's Customer Contracts Just Took the Memory Cycle Off the Table
Key PointsMicron has now inked a total of 26 strategic customer agreements that provide long-term pricing frameworks, up from 16 three months ago.
Micron's Customer Contracts Just Took the Memory Cycle Off the Table
Key PointsMicron has now inked a total of 26 strategic customer agreements that provide long-term pricing frameworks, up from 16 three months ago.
How Serbia’s Student List Movement is Challenging Vucic’s Grip
From Nepal to Czechoslovakia and Georgia, history offers plenty of examples of student protests forcing a government from office. Serbia’s students are taking a different approach: They’re trying to end leader Aleksandar Vucic’s decade-long rule through the ballot box.
Player ratings: Sanchez, Swanson get 9s in USWNT's comeback draw with Spain
A second-half rally against Spain, led by Ashley Sanchez and Mallory Swanson, will give USWNT coach Emma Hayes plenty to build on -- especially with the 2027 Women's World Cup on the horizon.
Nxera Pharma Signs Exclusive QUVIVIQ Licensing Deal With Synmosa For Eight Markets
(RTTNews) - Nxera Pharma Co., Ltd. (4565.T), a technology-powered biopharmaceutical company, on Wednesday announced an exclusive licensing, supply and commercialization agreement with Synmosa Biopharma Corp. (4114.TWO).
Nxera Pharma Signs Exclusive QUVIVIQ Licensing Deal With Synmosa For Eight Markets
(RTTNews) - Nxera Pharma Co., Ltd. (4565.T), a technology-powered biopharmaceutical company, on Wednesday announced an exclusive licensing, supply and commercialization agreement with Synmosa Biopharma Corp. (4114.TWO).
Best Growth Stocks to Buy for October 14th
ATI, BEKE, and VLO it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 14, 2026.